Literature DB >> 26151323

To build better tuberculosis diagnostics, look for 'biosignatures'.

Alan Dove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26151323     DOI： 10.1038/nm0715-662

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

Review 1.  Toward a unified biosignature for tuberculosis.

Authors:  Jeroen Maertzdorf; Stefan H E Kaufmann; January Weiner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-23       Impact factor: 6.915

2.  An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis.

Authors:  Deborah A Williamson; Indira Basu; James Bower; Joshua T Freeman; Gillian Henderson; Sally A Roberts
Journal:  Diagn Microbiol Infect Dis       Date:  2012-07-20       Impact factor: 2.803

3.  Diagnosis of childhood tuberculosis and host RNA expression in Africa.

Authors:  Suzanne T Anderson; Myrsini Kaforou; Andrew J Brent; Victoria J Wright; Lachlan J Coin; Robert S Heyderman; Michael Levin; Brian Eley; Claire M Banwell; George Chagaluka; Amelia C Crampin; Hazel M Dockrell; Neil French; Melissa S Hamilton; Martin L Hibberd; Florian Kern; Paul R Langford; Ling Ling; Rachel Mlotha; Tom H M Ottenhoff; Sandy Pienaar; Vashini Pillay; J Anthony G Scott; Hemed Twahir; Robert J Wilkinson
Journal:  N Engl J Med       Date:  2014-05-01       Impact factor: 91.245

4.  Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.

Authors:  N Sarita Shah; Prashini Moodley; Palav Babaria; Salona Moodley; Melissa Ramtahal; Jessica Richardson; Scott Heysell; Xuan Li; Anthony Moll; Gerald Friedland; A Willem Sturm; Neel R Gandhi
Journal:  Am J Respir Crit Care Med       Date:  2011-02-04       Impact factor: 21.405

5.  Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?

Authors:  Claudia M Denkinger; Madhukar Pai; David W Dowdy
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.